Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 3, 2002, Pages 1179-1189

  Kilts, Jason D ^a   Connery, Hilary S ^a   Arrington, Elaine G ^b   Lewis, Mechelle M ^a   Lawler, Cindy P ^c   Oxford, Gerry S ^a,d   O'Malley, Karen L ^a,e   Todd, Richard D ^c   Blake, Bonita L ^d   Nichols, David E ^e   Mailman, Richard B ^b  

^a Departments of Psychiatry Pharmacology Chemistry and Medicinal Chemistry   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALCIUM CHANNEL; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; N PROPYL DIHYDREXIDINE; POTASSIUM CHANNEL; PROLACTIN; PROPYLNORAPOMORPHINE; QUINPIROLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; GENETIC TRANSFECTION; INHIBITION KINETICS; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; RECEPTOR UPREGULATION;

ANIMALS; CELL LINE; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MEMBRANE POTENTIALS; PHENANTHRIDINES; PITUITARY GLAND, ANTERIOR; POTASSIUM CHANNELS; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; TRANSFECTION;

EID: 0036267278     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.3.1179     Document Type: Article

References (75)

1. Dopamine "autoreceptors": Pharmacological characterization by microiontophoretic single cell recording studies
2. 2 receptor to inhibition of adenylyl cyclase and prolactin secretion
3. Dialysis of lactotropes with antisense oligonucleotides assigns guanine nucleotide binding protein subtypes to their channel effectors
4. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus
5. 2) agonists and antagonists
6. 1 full agonist
7. 1 dopamine receptor ligands
8. 2A-adrenergic receptor signaling in Chinese hamster ovary cells: L-isoproterenol selectively activates G(s)
9. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity
10. 2 dopamine receptor cDNA
11. 2A-adrenergic receptor to multiple G-proteins. A simple approach for estimating receptor-G-protein coupling efficiency in a transient expression system
12. 50) of an enzymatic reaction
13. New roles for G-protein βγ-dimers in transmembrane signalling
14. Vip-induced cross-talk between G-proteins in membranes from rat anterior pituitary cells
15. 1 dopamine receptor agonist
16. + channels
17. 2 dopamine receptor activation of potassium channels in identified rat lactotrophs: Whole-cell and single-channel recording
18. 2 dopamine receptor activation of a potassium channel in rat lactotrophs
19. 2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary
20. 2+ channels
21. O regulates the peripheral actin network and catecholamine secretion by a mechanism involving the small GTP-binding protein Rho
22. 1A receptor
23. 2 receptor directs specificity of coupling to G-proteins
24. 1 receptor by several muscarinic ligands
25. Modulation of ion-channel function by G-protein-coupled receptors
26. Signaling pathways modulated by dopamine receptors
27. Dopamine receptors and brain function
28. The PACAP receptor: Generation by alternative splicing of functional diversity among G protein-coupled receptors in nerve cells
29. Differential signal transduction by six splice variants of the pituitary adenylate cyclase-activating peptide (PACAP) receptor
30. Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity
31. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals
32. Agonist-specific receptor conformations
33. G protein-coupled inward rectifier modulated by dopamine agonists in cultured substantia nigra neurons
34. 1 dopamine receptor agonist
35. 2L receptors couple to inward rectifier potassium channels in mammalian cell lines
36. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography
37. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes
38. A three-state receptor model of agonist action
39. 3 dopamine receptors in rat brain and pituitary gland: A quantitative autoradiographic study
40. Homologous desensitization of the D1A dopamine receptor: Efficacy in causing desensitization dissociates from both receptor occupancy and functional potency
41. 12 in GH4C1 pituitary cells
42. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist
43. Functional effects of novel dopamine ligands: Dihydrexidine and Parkinson's disease as a first step
44. 2 receptor are involved in functional G protein-mediated coupling to adenylate cyclase
45. 2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP
46. 2+ channels
47. Presynaptic receptors
48. 2 dopamine receptors produced by alternative RNA splicing
49. 2 receptors and G-proteins
50. 1 dopamine receptor agonist
51. 2 receptors linked to adenylyl cyclase
52. i1, leading to the inhibition of adenylate cyclase in transfected cell lines
53. 4 receptors
54. Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems
55. 1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells
56. Diversity of G proteins in signal transduction
57. Dopamine auto- and postsynaptic receptors: Electrophysiological evidence for differential sensitivity to dopamine agonists
58. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist
59. Detection and measurement of secretion from individual neuroendocrine cells using a reverse hemolytic plaque assay
60. 3) as a target for neuroleptics
61. Differential signal transduction by five splice variants of the PACAP receptor
62. Modulation of neurotransmitter release by presynaptic autoreceptors
63. Complexity and diversity of mammalian adenylyl cyclases
64. + channels by dopamine in human GH-producing cells
65. 4 dopamine receptors in fibroblast and dopaminergic cell lines
66. 3 receptors inhibit dopamine release
67. 2 receptor
68. Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors
69. Dopamine D1 receptors: Efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents
70. 4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes
71. Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: Microiontophoretic studies
72. Recombinant G-protein βγ-subunits activate the muscarinic-gated atrial potassium channel
73. 2+ channels via a membrane-delimited pathway
74. Dopamine D2 receptor isoforms expressed in AtT20 cells differentially couple to G proteins to acutely inhibit high voltage-activated calcium channels
75. Transmitter release by non-receptor activation of the α-subunit of guanine nucleotide regulatory protein in rat striatal slices